Why the study?
Perivascular adipose tissue directly impacts vessel function, structure, and contractility in obesity-associated diseases, but the role of myeloid GRK2 in modulating PVAT-dependent vasodilation responses was unknown.
Does myeloid GRK2 deficiency prevent obesity-induced endothelial dysfunction mediated by perivascular adipose tissue?
Does myeloid GRK2 deficiency prevent obesity-induced endothelial dysfunction mediated by perivascular adipose tissue?
Myeloid GRK2 is a potential therapeutic target for preventing obesity-induced endothelial dysfunction mediated by perivascular adipose tissue inflammation.
Suggests myeloid GRK2 involvement in obesity-related vascular dysfunction; hypothesis-generating and requires validation before clinical consideration.
Perivascular adipose tissue (PVAT) is increasingly being regarded as an important endocrine organ that directly impacts vessel function, structure, and contractility in obesity-associated diseases. We uncover here a role for myeloid G protein-coupled receptor kinase 2 (GRK2) in the modulation of PVAT-dependent vasodilation responses. GRK2 expression positively correlates with myeloid- (CD68) and lymphoid-specific (CD3, CD4, and CD8) markers and with leptin in PVAT from patients with abdominal aortic aneurysms. Using mice hemizygous for GRK2 in the myeloid lineage (LysM-GRK2+/−), we found that GRK2 deficiency in myeloid cells allows animals to preserve the endothelium-dependent acetylcholine or insulin-induced relaxation, which is otherwise impaired by PVAT, in arteries of animals fed a high fat diet (HFD). Downregulation of GRK2 in myeloid cells attenuates HFD-dependent infiltration of macrophages and T lymphocytes in PVAT, as well as the induction of tumor necrosis factor-α (TNFα) and NADPH oxidase (Nox)1 expression, whereas blocking TNFα or Nox pathways by pharmacological means can rescue the impaired vasodilator responses to insulin in arteries with PVAT from HFD-fed animals. Our results suggest that myeloid GRK2 could be a potential therapeutic target in the development of endothelial dysfunction induced by PVAT in the context of obesity.
No takes yet. Share an insight, caveat, or question.
González‐Amor et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: